MAIA Biotechnology, Inc. General form of registration statement for all companies including face-amount certificate companies

Accrued Expenses

9 Months Ended

12 Months Ended

Sep. 30, 2022

Dec. 31, 2021

3.	ACCRUED EXPENSES

As of September 30, 2022 and December 31, 2021, accrued expenses consisted of the following:

	September 30,		December 31,
	2022		2021
Bonus	$	781,647	$	384,750
Professional fees		70,922		380,277
Research and development costs		514,676		268,140
Deferred compensation to former officers		32,594		111,271
Other		37,361		41,157
Total accrued expenses	$	1,437,200	$	1,185,595

3.	ACCRUED EXPENSES

As of December 31, 2021 and 2020, accrued expenses consisted of the following:

	December 31,
	2021		2020
Bonus	$	384,750		780,000
Interest		—		12,678
Professional fees		380,277		46,132
Research and development costs		268,140		—
Other		41,157	$	—
Total accrued expenses	$	1,074,324	$	838,810